Functional variant of IL33 is associated with survival of osteosarcoma patients
Conclusions: Variant rs55933544 was associated with the survival time of OS patients. IL33 may contribute to a poor prognosis of OS. Further investigation into the biological mechanisms by which IL33 influences the overall survival can shed light on the improvement of clinical outcome for OS patients.
Source: Journal of Bone Oncology - Category: Cancer & Oncology Source Type: research
More News: Bone Cancers | Cancer & Oncology | Genetics | Osteosarcoma | Students | Study | Universities & Medical Training